<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02106208</url>
  </required_header>
  <id_info>
    <org_study_id>INAF-2013-251</org_study_id>
    <nct_id>NCT02106208</nct_id>
  </id_info>
  <brief_title>Study of the Impact of Dairy Fat on Cardiovascular Health.</brief_title>
  <acronym>HDL</acronym>
  <official_title>Study of the Impact of Dairy Fat on Cardiovascular Health.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agriculture and Agri-Food Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dairy Farmers of Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Market trends depicted by Agriculture and Agri-Food Canada suggest stagnation in cheese
      consumption, with potentially important impact on this key industry in Canada. This is in
      part due to the commonly accepted notion that saturated fat in the diet, of which cheese
      contributes significantly, increases the risk of heart disease. Yet, a rather large body of
      recent evidence suggests that saturated fat may have been unfairly demonized and that its
      impact on the risk of heart disease may in fact be less important than originally thought.
      This concept that dairy fat increases the risk of heart attacks therefore needs to be
      revisited, and this is one of the key objectives of this proposed research program.

      The proposed research is designed to investigate for the first time if dairy fat improves the
      levels of the so-called &quot;good cholesterol&quot;, a protective risk factor that has been
      essentially ignored in the arguments supporting the reduction of saturated fat for heart
      health.

      Our hypothesis is that consumption of SFA from dairy (cheese) compared with a low fat diet
      and diets rich in MUFA and PUFA leads to favorable changes in plasma HDL-C concentrations and
      functional characteristics. Consumption of SFA from dairy (cheese) also increases LDL
      particle size, reduces inflammation and has no deleterious impact on plasma LDL-C and
      apolipoproteins B (apoB) concentrations compared with a low fat diet.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center randomized crossover controlled feeding study. Briefly, adult men and
      women will be recruited in the Quebec City and Winnipeg metropolitan area through the media
      (newspaper, radio), local lipid clinics and mailing lists (n=90).

      Participants will be randomized to a series of 5 experimental diets of 4 weeks each: 1-
      Cheese diet, 2- Butter diet, 3- Carbohydrate (CHO) diet, 4- MUFA diet, 5- PUFA diet. Usual
      energy intake will be estimated at the beginning of the study using validated tools.
      Experimental diets will be provided as part of a full feeding protocol under carefully
      controlled isocaloric conditions to maintain body weight constant. All meals and foods will
      be provided to participants so that control for energy and macronutrient intake will be
      optimized. The breakfast meal will represent approximately 30% of the daily energy intake
      whereas the lunch and dinner meals each will provide 35% of daily energy intake. Participants
      will be instructed to consume their entire meals. A seven-day cyclic menu will be used. The
      diets will be separated by washout periods of 4 weeks. Blood samples will be collected on two
      consecutive days before and after each dietary phase. The mean of the two consecutive
      measurements will be used in the analyses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in High-Density-Lipoproteins concentrations (HDL-C)</measure>
    <time_frame>4 weeks (end-point value)</time_frame>
    <description>Post-diet values will be compared; the primary analysis (pre-determined comparisons) are
Cheese vs Butter,
Cheese vs CHO, MUFA, PUFA
Butter vs. CHO, MUFA, PUFA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in HDL-C particle size and subclass</measure>
    <time_frame>4 weeks (end-point value)</time_frame>
    <description>Post-diet values will be compared; the primary analysis (pre-determined comparisons) are
Cheese vs Butter,
Cheese vs CHO, MUFA, PUFA
Butter vs. CHO, MUFA, PUFA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HDL cholesterol efflux</measure>
    <time_frame>4 weeks (end-point value)</time_frame>
    <description>In a subset of individual;
Post-diet values will be compared; the primary analysis (pre-determined comparisons) are
Cheese vs Butter,
Cheese vs CHO, MUFA, PUFA
Butter vs. CHO, MUFA, PUFA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Low Density Lipoproteins (LDL) particle size</measure>
    <time_frame>4 weeks (end-point value)</time_frame>
    <description>Post-diet values will be compared; the primary analysis (pre-determined comparisons) are
Cheese vs Butter,
Cheese vs CHO, MUFA, PUFA
Butter vs. CHO, MUFA, PUFA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in C-Reactive Proteins (CRP) concentrations</measure>
    <time_frame>4 weeks (end-point value)</time_frame>
    <description>Post-diet values will be compared; the primary analysis (pre-determined comparisons) are
Cheese vs Butter,
Cheese vs CHO, MUFA, PUFA
Butter vs. CHO, MUFA, PUFA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in adiponectin concentrations</measure>
    <time_frame>4 weeks (end-point value)</time_frame>
    <description>Post-diet values will be compared; the primary analysis (pre-determined comparisons) are
Cheese vs Butter,
Cheese vs CHO, MUFA, PUFA
Butter vs. CHO, MUFA, PUFA</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">103</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Cheese diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 4-week experimental diet with all meals and foods be provided to participants, including 90g of regular cheddar cheese daily per 2500 kcal. The diet will contain 13% of saturated fat (SFA), 14% of mono-unsaturated fat (MUFA), 5% of polyunsaturated fat (PUFA) and 53% of carbohydrate (CHO).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Butter diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 4-week experimental diet with all meals and foods be provided to participants, the diet will contain 13% of SFA mostly from butter. The diet will contain 14% of MUFA, 5% of PUFA and 53% of CHO.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHO diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 4-week experimental diet with all meals and foods will provided to participants. The diet will contain 60% of CHO, 6% of SFA, 14% of MUFA and 5% of PUFA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MUFA diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 4-week experimental diet with all meals and foods be provided to participants. The diet will contain 21% of MUFA, 6% of SFA, 5% of PUFA and 53% of CHO.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PUFA diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A 4-week experimental diet with all meals and foods will be provided to participants. The diet will contain 12% of PUFA, 14% of MUFA, 6% of SFA and 53% of CHO.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cheese diet</intervention_name>
    <arm_group_label>Cheese diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Butter diet</intervention_name>
    <arm_group_label>Butter diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CHO diet</intervention_name>
    <arm_group_label>CHO diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MUFA diet</intervention_name>
    <arm_group_label>MUFA diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PUFA diet</intervention_name>
    <arm_group_label>PUFA diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women age between 18 and 65 years

          -  Waist circumference &gt;80.0 cm for women and &gt;94.0 cm for men

          -  Plasma concentration of triglycerides &gt;1.70 mmol / L

          -  Stable weight for 6 months before the start of the study (+/- 5lbs)

        Exclusion Criteria:

          -  Men or women aged under 18 years or over 65 years

          -  History of CVD, type 2 diabetes or dyslipidaemia monogenic

          -  Endocrine disorders

          -  Smoking

          -  Lipid lowering medications or hypertension medications

          -  Food allergies and aversions to any food in the composition of experimental menus

          -  Subjects with special dietary habits (e.g. vegetarianism)

          -  Subject with a calculated Framingham risk of cardiovascular disease (CVD) &gt; 20%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beno√Æt Lamarche, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Richardson Centre for Functional Foods and Nutraceuticals</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3T 6C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Nutrition and Funtional Foods</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2014</study_first_submitted>
  <study_first_submitted_qc>April 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2014</study_first_posted>
  <last_update_submitted>February 21, 2018</last_update_submitted>
  <last_update_submitted_qc>February 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Benoit Lamarche</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

